Despite that, treatment with saroglitazar and/or BrMSCs that was initiated 14 days after pulmonary fibrosis induction significantly (p < 0.05) reversed the decreased lung SOD levels in comparison to BLM-G. Here, SOD1 is linked to pulmonary fibrosis.